Terms: = Liver cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
947 results:
1. liver cancer development driven by the AP-1/c-jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract] [Full Text] [Related]
2. SLC7A11-ROS/αKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression.
Lv T; Fan X; He C; Zhu S; Xiong X; Yan W; Liu M; Xu H; Shi R; He Q
Redox Biol; 2024 Jun; 72():103159. PubMed ID: 38642501
[TBL] [Abstract] [Full Text] [Related]
3. Protective Effects and Mechanisms of Esculetin against H
Luo Y; Chang T; Huang S; Xiang J; Tang S; Shen H
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611695
[TBL] [Abstract] [Full Text] [Related]
4. Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer.
Yang H; Cheng J; Zhuang H; Xu H; Wang Y; Zhang T; Yang Y; Qian H; Lu Y; Han F; Cao L; Yang N; Liu R; Yang X; Zhang J; Wu J; Zhang N
Cancer Cell; 2024 Apr; 42(4):535-551.e8. PubMed ID: 38593780
[TBL] [Abstract] [Full Text] [Related]
5. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
6. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract] [Full Text] [Related]
7. Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis.
Zhang Z; Zhao Q; Wang Z; Xu F; Liu Y; Guo Y; Li C; Liu T; Zhao Y; Tang X; Zhang J
Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38437062
[TBL] [Abstract] [Full Text] [Related]
8. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
9. Hepa-ToxMOA: a pathway-screening method for evaluating cellular stress and hepatic metabolic-dependent toxicity of natural products.
Park SM; Choi MS; Kim S; Jegal H; Han HY; Chun HS; Kim SK; Oh JH
Sci Rep; 2024 Feb; 14(1):4319. PubMed ID: 38383711
[TBL] [Abstract] [Full Text] [Related]
10. jun/Fos promotes migration and invasion of hepatocellular carcinoma cells by enhancing BORIS promoter activity.
Xian L; Xiong Y; Qin L; Wei L; Zhou S; Wang Q; Fu Q; Chen M; Qin Y
Int J Biochem Cell Biol; 2024 Apr; 169():106540. PubMed ID: 38281696
[TBL] [Abstract] [Full Text] [Related]
11. Cell mechanics regulate the migration and invasion of hepatocellular carcinoma cells via JNK signaling.
Wang J; Zhang B; Chen X; Xin Y; Li K; Zhang C; Tang K; Tan Y
Acta Biomater; 2024 Mar; 176():321-333. PubMed ID: 38272199
[TBL] [Abstract] [Full Text] [Related]
12. Regucalcin downregulation in human cancer.
Ghanem NZ; Yamaguchi M
Life Sci; 2024 Mar; 340():122448. PubMed ID: 38246519
[TBL] [Abstract] [Full Text] [Related]
13. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments.
Li S; Liu W; Wang TT; Chen TQ; Guo JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14428. PubMed ID: 38230768
[TBL] [Abstract] [Full Text] [Related]
14. ZBTB7B is a permissive regulator of hepatocellular carcinoma initiation by repressing c-jun expression and function.
Zhu Y; Wang Q; Xie X; Ma C; Qiao Y; Zhang Y; Wu Y; Gao Y; Jiang J; Liu X; Chen J; Li C; Ge G
Cell Death Dis; 2024 Jan; 15(1):55. PubMed ID: 38225233
[TBL] [Abstract] [Full Text] [Related]
15. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
Fan W; Cao D; Yang B; Wang J; Li X; Kitka D; Li TWH; You S; Shiao S; Gangi A; Posadas E; Di Vizio D; Tomasi ML; Seki E; Mato JM; Yang H; Lu SC
J Hepatol; 2024 Mar; 80(3):443-453. PubMed ID: 38086446
[TBL] [Abstract] [Full Text] [Related]
16. Inter-patient heterogeneity in the hepatic ischemia-reperfusion injury transcriptome: Implications for research and diagnostics.
Groiss S; Viertler C; Kap M; Bernhardt G; Mischinger HJ; Sieuwerts A; Verhoef C; Riegman P; Kruhøffer M; Svec D; Sjöback SR; Becker KF; Zatloukal K
N Biotechnol; 2024 Mar; 79():20-29. PubMed ID: 38072306
[TBL] [Abstract] [Full Text] [Related]
17. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
[TBL] [Abstract] [Full Text] [Related]
18. Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitate.
Deng R; Zheng Z; Hu S; Wang M; Feng J; Mattjus P; Zhang Z; Zhang Y
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119644. PubMed ID: 37996059
[TBL] [Abstract] [Full Text] [Related]
19. Reconstruction of the regulatory hypermethylation network controlling hepatocellular carcinoma development during hepatitis C viral infection.
Antropova EA; Khlebodarova TM; Demenkov PS; Volianskaia AR; Venzel AS; Ivanisenko NV; Gavrilenko AD; Ivanisenko TV; Adamovskaya AV; Revva PM; Kolchanov NA; Lavrik IN; Ivanisenko VA
J Integr Bioinform; 2023 Sep; 20(3):. PubMed ID: 37978846
[TBL] [Abstract] [Full Text] [Related]
20. Components of the JNK-MAPK pathway play distinct roles in hepatocellular carcinoma.
Yu J; Li X; Cao J; Zhu T; Liang S; Du L; Cao M; Wang H; Zhang Y; Zhou Y; Shen B; Feng J; Zhang J; Wang J; Jin J
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17495-17509. PubMed ID: 37902853
[TBL] [Abstract] [Full Text] [Related]
[Next]
